Ls. Elinder et al., SERUM LIPID-SOLUBLE ANTIOXIDANTS IN PATIENTS WITH HYPERLIPOPROTEINEMIA, NMCD. Nutrition Metabolism and Cardiovascular Diseases, 4(4), 1994, pp. 197-203
In 252 hyperlipoproteinemic subjects with or without symptoms of cardi
ovascular disease the serum concentrations of Vitamin E (alpha-tocophe
rol), vitamin A (retinol), lycopene, alpha-carotene, and beta-carotene
, collectively called serum lipid-soluble antioxidants, were measured.
Associations with serum lipids, constitutional, and life-style factor
s were investigated. These hyperlipoproteinemic individuals displayed
higher serum concentrations of antioxidants than normolipidemic subjec
ts, except for lycopene. Serum cholesterol and/or triglycerides were s
ignificant predictors of elevated serum antioxidant concentrations, an
d could together explain 36% of the total variability in serum vitamin
E, after adjusting for age, body mass index, dietary intake of vitami
n E, smoking, and alcohol consumption. Serum lipids explained 12% of t
he variability in p-carotene, 10% of that in vitamin A, 6% of that in
cu-carotene, and 4% of that in lycopene, after adjusting for age, body
mass index, smoking, and alcohol consumption. The relationship betwee
n serum lipids, taken as the sum of cholesterol and triglycerides, and
serum vitamin E was linear from 4.5 to 16 mmol/l of total lipids. Lip
id standardization of the serum vitamin A and E and p-carotene concent
rations to a level of 7 mmol/l of serum lipids showed that this group
of hyperlipoproteinemic subjects was above the proposed European risk
thresholds concerning dietary antioxidants and cardiovascular disease.
The serum lycopene concentration was found to be lower in subjects wi
th cardiovascular disease symptoms than in those without. However, aft
er adjusting for age, this apparent difference disappeared.